Stay updated on Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial
Sign up to get notified when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.

Latest updates to the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.6.5, indicating a recent update to the record. This is a metadata-only change and does not alter the study details presented on the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.6.4 instead of Revision: v3.6.3, indicating a recent update to the page. This change does not modify any study data or core functionality.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page Revision label was updated from v3.6.2 to v3.6.3, indicating a new release of the page. This appears to be a backend/UI update rather than substantive changes to the study details.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision tag was updated to v3.6.2, indicating a new release version of the page. This appears to be a small maintenance update to the page structure or rendering rather than substantive content changes.SummaryDifference0.0%

- Check58 days agoChange DetectedRecruitment status now shows that enrollment is closed. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and there is a minor label formatting change (Intervention/Treatment) along with a new revision badge.SummaryDifference0.4%

- Check65 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, reflecting a minor maintenance update to the page. It does not appear to modify study data, eligibility criteria, or presented content.SummaryDifference0.0%

Stay in the know with updates to Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.